Klebsiella pneumoniae is gram-negative, rod-shaped, aerobic and facultative anaerobic, nonmotile, nitrate positive, and has large polysaccharide capsules (Brooks et al., 2004). It belongs to the Enterobacteriaceae family and the genus Klebsiella. It is also an opportunistic pathogen, capable of infecting humans and other animal species with a variety of diseases. It belongs to the ESKAPE group of bacteria (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumanii, Pseudomonas aeruginosa, and Enterobacter specie) that effectively 'escape' the effects of antibacterial drugs (Von Gottberg et al., 2001).
In terms of habitat associations, the genus Klebsiella is diverse. It is the second most common member of the human intestine's aerobic bacterial flora. It is flora that is either resident or transient in the gastrointestinal system (Seaton, 2000). In humans, K. pneumoniae is mostly found in the gastrointestinal tract, with a few isolated cases in the nasopharynx, where it can reach the bloodstream or other tissues, causing illness (Chiang et al., 2010). Humans, animals, sewage, drinking water, surface waterways, polluted water, industrial effluents, and vegetation are examples of other habitats (Ferragut et al., 2004).
Bacteria identification is very important in microbiology and pathology as it serves a basis of understanding diseases. Klebsiella was first identified as a cause of pneumonia by pathologist Karl Friedlander in 1882, and capsular polysaccharide has been identified as the species' most distinguishing feature and most studied virulence component. Friedlander isolated a capsulated bacillus from the lungs of a patient who had died of pneumonia in 1883, and the microorganism was given its name Friedlander’s bacillus .It was later identified as Klebsiella and is now reported worldwide (Eisenstadt and Crane,1994).
Clinical strains of K. pneumoniae can be separated into two groups based on the accessory genome: the classical group (cKp), which includes MDR strains, and the hypervirulent (hvKp) group (Martin 2018). cKp strains are commonly found in the gastrointestinal (GI) tract of patients with intestinal. HvKp strains are considered serious pathogens and can cause community-acquired, aggressive, and metastatic infections, as well as liver abscesses, pneumonia, endophthalmitis, meningitis, and septic arthritis (Russo 2019).
K.pneumoniae is the most common cause of liver swelling, Gram-negative bacillary meningitis, brain abscess, lung abscess, thoracic empyema, prostatic abscess, deep neck infection, and complicated skin and soft tissue infections, accounting for 4.8 percent of community acquired pneumonia (CAP) pathogens (Chang, 2008). It is one of the most common bacteria that causes severe epidemic and endemic nosocomial infections in hospitals. Septicaemia, neonatal septicaemia, intra-abdominal infections, and bloodstream infections (BSIs) are all common causes (Ramphal and Ambrose, 2006). It is an opportunistic bacterium that can colonize the mucosal epithelium of the stomach and nasopharynx, then move to vulnerable patients' deep tissues and bloodstreams, causing serious infections including endophthalmitis (Donskey, 2004). These infections are difficult to cure because of the pathogen's high inherent antibiotic resistance. Infection with multidrug-resistant gram-negative bacteria is linked to a high rate of morbidity and mortality (Patel et al., 2009). It is caused by the microbiota of the patient. The loss of microbiota colonization resistance causes a bloom of K. pneumoniae cells in the digestive tract, which is thought to be an early stage in the progression of the disease. Indwelling systems such urine catheters, feeding tubes, and central blood catheters are well-known risk factors for Klebsiella infection. Antibiotic resistance in Klebsiella species spread due to the use of ineffective antibiotics. Furthermore, widespread use of broad-spectrum antibiotics in hospitalized patients has resulted in increased Klebsiella carriage as well as the emergence of multidrug-resistant strains. Antimicrobial resistance caused by K. pneumoniae can have serious consequences, including increased morbidity, mortality, and even longer hospital stays. (Li & Webster, 2018 and Pacios et al., 2020). In order to implement effective control measures to prevent rapid spread of drug resistance, it is critical to understand the antimicrobial susceptibility pattern of Klebsiella, which differs in different geographical settings (Namratha, 2015). Following that, the use of third-generation cephalosporins like ceftriaxone, cefotaxime, and ceftazidime was limited to the treatment of K .pneumoniae infections. K. pneumoniae carbapenemases (KPC) is resistant to carbapenem, amino glycosides, cephalosporins, and fluoroquinolones, despite the fact that it is usually sensitive to the antibiotic colistin. This makes it a highly resistant bacterium that currently requires the use of three different antibiotics to treat the infection successfully (Johnson et al., 2011). Colistin, tigecycline, and gentamicin are the current antibiotic combinations used to treat K. pneumoniae infections. The indiscriminate use of colistin has resulted in several cases of K. pneumoniae resistance (Feizabadi and Etemadi, 2007).
The present study was done to identify different strains of K. pneumoniae through morphological and biochemical characterization using several assays and to screen the antibiotic susceptibility pattern of K. pneumoniae.